Ancora Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Ancora Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-50,000	Closed	-$257K	–	515
2014 Q3	$257K	Sell	50,000 -40,000	-44%	-$213K	0.03%	388
2014 Q2	$472K	Sell	90,000 -40,000	-31%	-$173K	0.06%	315
2014 Q1	$541K	Sell	130,000 -20,000	-13%	-$68.6K	0.08%	282
2013 Q4	$438K	Buy	150,000 +13,592	+10%	+$33.7K	0.07%	279
2013 Q3	$344K	Buy	136,408 +82,808	+154%	+$196K	0.06%	294
2013 Q2	$111K	Buy	+53,600	New	+$118K	0.02%	393

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ancora Advisors's ENZ Position: Q4 2014 in Review

Ancora Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q4 2014, closing a stake of 50,000 shares — an estimated $257K sold.

Ancora Advisors first reported a position in ENZ in Q2 2013 and held it in 6 quarters. The position peaked at $541K in Q1 2014. 87 funds tracked by Wall St. Rank hold ENZ as of Q4 2014.

Ancora Advisors reported no remaining Enzo Biochem, Inc. position as of Q4 2014 after selling out during the quarter.
Ancora Advisors sold 50,000 Enzo Biochem, Inc. shares in Q4 2014, an estimated $257K.
Ancora Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 6 quarters.
Ancora Advisors's Enzo Biochem, Inc. position peaked at $541K in Q1 2014.
87 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2014.

Based on Ancora Advisors's 13F filing for Q4 2014, filed 11 Feb 2015.